RENBP and lymphoproliferative syndrome: For example, patients at high risk (especially patients with initial FVIII <1%; patients with a lymphoproliferative disorder) could be selected for closer monitoring by using FVIII:C/VWF:Ag ratio and by analyzing the immunoglobulin G subclasses of FVIII autoantibodies as supplementary laboratory markers.